Glenmark gets USFDA nod for generic skin inflammation oil

New Delhi: Glenmark Pharmaceuticals Friday said its US arm has received final nod from the US health regulator for generic Fluocinolone Acetonide Topical oil used for treatment of inflammation of skin. Glenmark Pharmaceuticals Inc has been granted final approval by the United States Food & Drug Administration (USFDA) for the oil in the strength of 0.01 per cent, the Mumbai-based company said in a statement.

The product is a generic version of Hill Dermaceuticals Inc’s Derma-Smoothe/FS Topical oil in the same strength, it added.

The body oil is indicated for the topical treatment of atopic dermatitis in adult patients.

“According to IQVIA sales data for the 12 months ended August 2018, the Derma-Smoothe/FS Topical oil, 0.01 per cent market (including brand and available therapeutic equivalents) achieved annual sales of approximately USD 14.5 million,” Glenmark Pharma said.

The company’s current portfolio consists of 140 products authorised for distribution in the US and 60 abbreviated new drug applications (ANDAs) pending approval with the USFDA, it added.

Shares of Glenmark Pharma were trading at Rs 592.25 per scrip on BSE, down 3.33 per cent from the previous close.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 188 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 272 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra